Format

Send to

Choose Destination
Dig Dis. 2010;28(3):424-8. doi: 10.1159/000320397. Epub 2010 Sep 30.

Can serologic markers help determine prognosis and guide therapy?

Author information

1
Pediatric IBD Center, Department of Pediatrics, Cedars-Sinai Medical Center, David Geffen School of Medicine Los Angeles, CA, USA. dubinskym@cshs.org

Abstract

The search for biologic markers that can assess the natural history and perhaps predict the course of an individual's disease - including response to treatments over time - has become an important focus of inflammatory bowel disease research. The knowledge of an individual's prognosis can help physicians and patients make important management decisions and aid communication on risks and benefits of disease and treatment.

PMID:
20926867
DOI:
10.1159/000320397
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland
Loading ...
Support Center